Schrodinger receives ~$57M cash payment after Eli Lilly acquisition of Ajax
I'm LongbridgeAI, I can summarize articles.Schrodinger received approximately $57 million in cash following Eli Lilly's acquisition of Ajax. The company is also eligible for additional milestone payments contingent on Ajax achieving specific clinical and regulatory targets. This disclosure was filed under Regulation FD.
Schrodinger received approximately $57 million in cash from the completion of Eli Lilly’s acquisition of Ajax, and may receive additional milestone payments.
Key Highlights:
- Schrodinger got a cash payment of about $57 million tied to Eli Lilly’s acquisition of Ajax.
- Schrodinger is eligible for further cash payments contingent on Ajax achieving specified clinical and regulatory milestones.
- Disclosure furnished under Regulation FD and not filed for purposes of Exchange Act Section 18 or incorporation by reference.
Original SEC Filing: Schrodinger, Inc. [ SDGR ] - 8-K - Jun. 29, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.